A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

Authors:

Abstract
No abstract available

This publication has 35 references indexed in Scilit: